September 18, 2025 - 00:27

Susan Monarez, the former head of the Centers for Disease Control and Prevention, recently testified before a Senate committee regarding her controversial dismissal by Health Secretary Robert F. Kennedy Jr. Monarez asserted that her termination was a direct result of her steadfast commitment to maintaining scientific integrity within the agency.
In her statements, she emphasized the importance of evidence-based decision-making in public health, arguing that Kennedy's approach poses a significant risk to the well-being of the public. Monarez expressed concerns over the potential consequences of undermining scientific principles in health policy, suggesting that such actions could lead to misguided strategies that endanger lives.
The Senate committee's hearing highlighted the ongoing tensions within the health department, as well as the broader implications of leadership decisions on public health initiatives. Monarez's testimony has sparked a renewed debate about the role of science in health governance and the responsibilities of public health officials to uphold rigorous standards.
November 2, 2025 - 01:58
Important Information on Atorvastatin Pill RecallIf you are using atorvastatin, a popular medication for lowering cholesterol, recent news has highlighted a significant recall affecting thousands of bottles. This recall, which began in late...
November 1, 2025 - 17:20
Rising Health Insurance Costs: What You Need to KnowAs the annual ACA Open Enrollment period approaches, many individuals and families may find themselves facing higher health insurance premiums. Several factors contribute to this trend, including...
October 31, 2025 - 22:54
FDA Takes Steps to Limit Prescription Fluoride SupplementsThe US Food and Drug Administration announced on Friday that it is moving forward to restrict the use of prescription fluoride supplements. This decision comes in response to a directive from the...
October 31, 2025 - 06:21
Navigating ACA Health Plans During Open EnrollmentThis year, with Congress in a stalemate about subsidies, Affordable Care Act marketplace consumers will need to be more informed than ever to navigate their health coverage choices. As open...